Evidence map›Paper›PMID 27956551›Full record

ArticleThe Journal of biological chemistry2017

Recombinant Expression of the Full-length Ectodomain of LDL Receptor-related Protein 1 (LRP1) Unravels pH-dependent Conformational Changes and the Stoichiometry of Binding with Receptor-associated Protein (RAP).

Camilla De Nardis, Philip Lössl, Maartje van den Biggelaar, Pramod K Madoori, Nadia Leloup, Koen Mertens, Albert J R Heck, Piet Gros

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Site-specificThe Journal of biological chemistry · 2018
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Camilla De NardisFrom the Crystal & Structural Chemistry Group, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht.
Philip Lösslthe Biomolecular Mass Spectrometry & Proteomics Group and Netherlands Proteomics Center, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CH Utrecht.
Maartje van den Biggelaarthe Department of Plasma Proteins, Sanquin Research, 1006 AN Amsterdam, and.
Pramod K MadooriFrom the Crystal & Structural Chemistry Group, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht.
Nadia LeloupFrom the Crystal & Structural Chemistry Group, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht.
Koen Mertensthe Department of Plasma Proteins, Sanquin Research, 1006 AN Amsterdam, and.ORCID 0000-0002-4134-6898
Albert J R Heckthe Biomolecular Mass Spectrometry & Proteomics Group and Netherlands Proteomics Center, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CH Utrecht.ORCID 0000-0002-2405-4404
Piet GrosFrom the Crystal & Structural Chemistry Group, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht, p.gros@uu.nl.ORCID 0000-0002-7782-2585
Utrecht University · NLUniversity of Applied Sciences Utrecht · NLSanquin · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LDL receptor-related protein 1 (LRP1) is a highly modular protein and the largest known mammalian endocytic receptor. LRP1 binds and internalizes many plasma components, playing multiple crucial roles as a scavenger and signaling molecule. One major challenge to studying LRP1 has been that it is difficult to express such a large, highly glycosylated, and cysteine-rich protein, limiting structural studies to LRP1 fragments. Here, we report the first recombinant expression of the complete 61 domains of the full-length LRP1 ectodomain. This advance was achieved with a multistep cloning approach and by using DNA dilutions to improve protein yields. We investigated the binding properties of LRP1 using receptor-associated protein (RAP) as a model ligand due to its tight binding interaction. The LRP1 conformation was studied in its bound and unbound state using mass spectrometry, small-angle X-ray scattering, and negative-stain electron microscopy at neutral and acidic pH. Our findings revealed a pH-dependent release of the ligand associated with a conformational change of the receptor. In summary, this investigation of the complete LRP1 ectodomain significantly advances our understanding of this important receptor and provides the basis for further elucidating the mechanism of action of LRP1 in a whole and integrated system.

Indexed as

GlycosylationHEK293 CellsHumansHydrogen-Ion ConcentrationLow Density Lipoprotein Receptor-Related Protein-1Protein DomainsRecombinant ProteinsStructure-Activity RelationshipX-Ray DiffractionLow Density Lipoprotein Receptor-Related Protein-1LRP1 protein, humanRecombinant Proteinselectron microscopy (EM)LRP1mass spectrometry (MS)pH regulationreceptor-associated proteinsmall-angle X-ray scattering (SAXS)surface plasmon resonance (SPR)

Identifiers

PMID27956551
PMCPMC5247663
OpenAlexW2563055933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.